Arkolith/Insider Trading/XLRN/Form 4

Kango Sujay

EVP, Chief Commercial OfficerACCELERON PHARMA INC (XLRN) · full profile →Form 4 · filed Sep 27, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$875K
Net Open-Market Flow
-$875K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2021Option exercise(M)5K$40.61$203K24K
Sep 27, 2021Sell(S)5K$175.00$875K19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 27, 2021Option exercise(M)5K—$025K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-008949) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML